Nido Biosciences

About:

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

Top Investors: Eli Lilly, Bessemer Venture Partners, OUP (Osage University Partners), Abingworth, 5AM Ventures

Description:

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.

Total Funding Amount:

$109M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Jamil M. Beg

Number of Employees:

11-50

Last Funding Date:

2023-05-15

IPO Status:

Private

Industries: